Program Intellectual Property. GSK will own all right, title and interest in and to the Program Intellectual Property , including any intellectual property rights appurtenant thereto. ADVANCIS hereby assigns to GSK all its rights to and interest in Inventions within Program Intellectual Property made by ADVANCIS, its Affiliates or their Contractors engaged in the work performed pursuant to Sections 3.1 or Section 3.4(c), and will ensure that any agreements with Affiliates and Contractors include the assignment of such Inventions to ADVANCIS or directly to GSK. ADVANCIS will cooperate with GSK with respect to patent filing, prosecution and enforcement of such inventions within Program Intellectual Property.
Appears in 2 contracts
Sources: Development and License Agreement (Advancis Pharmaceutical Corp), Development and License Agreement (Advancis Pharmaceutical Corp)